HKG/1276 (HKG/1276)

Hong Kong Stock Exchange: HKG/1276 · HKD

HK$49.6

+4.84 (+10.8%)· Recorded snapshot

Market cap	374.8B
Revenue (ttm)	38.4B
Net income (ttm)	10.4B
EPS (ttm)	HK$1.58
P/E (trailing)	31.4x
P/E (forward)	32.1x
Dividend	HK$0.23 (0.46%)
Volume	16,164,105
Beta	0.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.4B
Net income (ttm): 10.4B
EPS (ttm): HK$1.58
P/E (trailing): 31.4x
P/E (forward): 32.1x
Market cap: 374.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E32.1

P25 n/aP50 n/aP75 n/a

Trailing P/E31.4

P25 n/aP50 n/aP75 n/a

ROE13.9

P25 n/aP50 n/aP75 n/a

ROIC31.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HKG/1276 indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	HKD
Country	China
Country code	HK
Earnings date	2026-10-27
Employees	20,602
Employees change	364
Employees growth	1.8%
Enterprise value	HKD 324.6B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1970
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	CNE100006XS6
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	HKD 374.8B
Next earnings date	2026-11-02
Price	HKD 49.56
Price currency	HKD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	hkg/1276
Website	https://www.hengrui.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	61.6x
Average P/E ratio (3Y)	51.43x
Average P/E ratio (5Y)	57.1x
Earnings yield	3.18%
EV/Earnings	31.24x
EV/EBIT	30.61x
EV/EBITDA	27.82x
EV/FCF	45.87x
EV/Sales	8.4x
FCF / EV yield	2.18%
FCF yield	1.89%
Forward P/E	32.08x
Graham number	17.94582
Graham upside	-63.79%
Industry forward P/E	14.61x
Industry P/E	21.74x
Lynch fair value	HKD 9.88
Lynch upside	-80.06%
P/B ratio	4.76x
P/E ratio	31.45x
P/FCF ratio	52.95x
P/OCF ratio	32.14x
P/S ratio	9.75x
Price / tangible book value	5.09x
Price/EBITDA ratio	32.44x
Sector forward P/E	23.73x
Sector P/E	41.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	27.44%
EBITDA margin	30.06%
Effective tax rate	11.42%
FCF margin	18.31%
Gross margin	86.36%
Operating margin	27.44%
Pretax margin	30.52%
Profit margin	27.04%
Profit per employee	HKD 504,409
Profitable quarters	33
Profitable years	20
Revenue per employee	HKD 1.9M
ROA	7.77%
ROA (5Y)	6.83%
ROCE	12.91%
ROE	13.94%
ROE (5Y)	12.69%
ROIC	31.67%
ROIC (5Y)	23.83%
Tax / revenue	3.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	15.42%
EPS growth (Q)	-14.64%
EPS growth (QoQ)	0%
EPS growth 10Y	12.92%
EPS growth 3Y	26.64%
EPS growth 5Y	6.45%
EPS growth years	3
FCF growth	-38.19%
FCF growth (Q)	-89.69%
FCF growth (QoQ)	301.67%
FCF growth 3Y	57.17%
FCF growth 5Y	33.58%
Gross profit growth	6.09%
Gross profit growth (Q)	-16.2%
Gross profit growth 3Y	14.6%
Gross profit growth 5Y	2.71%
Net income growth	18.95%
Net income growth (Q)	-15.25%
Net income growth (QoQ)	-4.34%
Net income growth 3Y	28.29%
Net income growth 5Y	7.19%
Net income growth years	3
OCF growth	-16.57%
OCF growth (Q)	-67.95%
OCF growth (QoQ)	52.66%
OCF growth 10Y	14.15%
OCF growth 3Y	43.32%
OCF growth 5Y	27.63%
Operating income growth	15.35%
Operating income growth (Q)	-39.96%
Operating income growth 3Y	36.93%
Operating income growth 5Y	7.7%
Revenue growth	6.03%
Revenue growth (Q)	-14.5%
Revenue growth (QoQ)	-10.14%
Revenue growth 10Y	11.86%
Revenue growth 3Y	13.71%
Revenue growth 5Y	2.87%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	HKD -4.6B
Depreciation and amortization	HKD 1B
EBIT	HKD 10.5B
EBITDA	HKD 11.6B
EPS	HKD 1.58
Financing cash flow	HKD -2B
Free cash flow	HKD 7.1B
Gross profit	HKD 33.2B
Income taxes	HKD 1.3B
Investing cash flow	HKD -4.7B
Net borrowing	HKD -147.2M
Net cash flow	HKD 3.5B
Net income	HKD 10.4B
Operating income	HKD 10.5B
Revenue	HKD 38.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	26.04
Book value per share	HKD 11.85
Debt / EBITDA	0.04
Debt / equity	0.01
Debt / FCF	0.07
Interest coverage	1,503.27
Long-term assets	HKD 31.4B
Long-term liabilities	HKD 6B
Net cash (debt)	HKD 50.5B
Net cash / market cap	13.46%
Net cash growth	7.29%
Net debt / EBITDA	-4.37
Net debt / equity	-0.64
Net debt / FCF	-7.13
Piotroski F-Score	6
Property, plant and equipment	HKD 10B
Shareholders' equity	HKD 78.8B
Tangible book value	HKD 73.6B
Tangible book value per share	HKD 11.16
Total assets	HKD 89.7B
Total cash	HKD 51B
Total debt	HKD 493.3M
Total liabilities	HKD 11B
WACC	4.47%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	HKD 58.4B
Current liabilities	HKD 5B
Current ratio	7.91
Inventory turnover	1.55
Net working capital	HKD 5.3B
Quick ratio	7.25
Working capital	HKD 55.7B
Working capital turnover	0.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.06%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-05-27
Dividend payment years	1
Dividend per share	HKD 0.23
Dividend yield	0.46%
Ex-dividend date	2026-04-29
Last dividend	HKD 0.23
Payout ratio	15.06%
Shareholder yield	-2.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	HKD 56.11
1D price change	10.82%
1M price change	9.7%
1M total return	9.7%
1W price change	-0.04%
1W total return	-0.04%
1Y price change	-37.86%
1Y return CAGR	-37.66%
1Y total return	-37.64%
20-day SMA	HKD 47.97
200-day SMA	HKD 59.51
3M price change	-13.13%
3M total return	-13.13%
50-day SMA	HKD 47.30
50-day SMA vs 200-day SMA	50under200
52-week high	HKD 80.95
52-week high date	2026-01-14
52-week low	HKD 43.02
52-week low date	2026-09-14
6M price change	-26.69%
6M total return	-26.43%
All-time high	HKD 95.20
All-time high date	2025-10-02
All-time low	HKD 43.02
All-time low date	2026-09-14
Average true range (ATR)	HKD 2.48
Average volume	5.6M
Beta (5Y)	0.04
Change from 52-week high	-38.78%
Change from 52-week low	15.2%
Change from all-time high	-47.94%
Change from all-time low	15.2%
Change from open	7.74%
Day's gap	2.86%
Dollar volume	HKD 801.1M
High price	HKD 50.90
Low price	HKD 45.98
Monthly RSI	44.73
Open price	HKD 46.00
Position in 52-week range	72.76%
Previous close	HKD 44.72
Price vs 150-day SMA	-11.67%
Price vs 20-day SMA	3.31%
Price vs 200-day SMA	-16.72%
Price vs 50-day SMA	4.78%
Relative volume	2.95
RSI	55.21
Sharpe ratio	-0.96
Sortino ratio	-1.26
Volume	16.2M
Weekly RSI	42.75
YTD price change	-30.44%
YTD total return	-30.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.7B
Shares change (QoQ)	-4.34%
Shares change (YoY)	3.06%
Shares held by insiders	0.08%
Shares held by institutions	27.86%

Deeper analysis on HKG/1276

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HKG/1276 report

Is a complete HKG/1276 research report available?

No complete published report is available for hkg/1276 (HKG/1276) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

HKG/1276 (HKG/1276)

Price

Financial snapshot

Fair-value bridge

Latest news · HKG/1276

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HKG/1276 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HKG/1276

Frequently asked questions